We all know that the US healthcare system tends to focus more on treatment than prevention. Even hospital systems and medical facilities naturally tend to focus less on proactive care than reactive care models. However, the emergence of artificial intelligence technology (AI) will enable a new era of preventive, patient-centric care. Fueled by vast troves of patient data, AI is transforming early diagnosis and treatment plans by predicting patient outcomes and overhauling outdated prior authorization processes, enabling physicians to further help their patients achieve faster, better outcomes.

Untangling the web of patient data

Patient data, encompassing electronic medical records (EMRs), medical imaging, and genetic information, holds untapped valuable information that can be better used to get patients the right care faster. With the ability to process and analyze extensive data at unprecedented scale and speed, AI delves deeply into population health data, allowing for precise, patient cohort-specific predictions. This empowers physicians to anticipate potential health issues and intervene proactively for optimal patient outcomes.

AI’s individual-level analysis of patient data enables personalized treatment plans, replacing a one-size-fits-all approach to care. Healthcare providers can tailor interventions to each patient’s unique needs, considering factors such as genetics, lifestyle, and environmental influences to optimize care. These plans can improve care quality and reduce adverse reactions, hospital readmissions, and treatment-related complications. This synergy is giving rise to an era wherein predictive analytics and decision support systems will become indispensable tools.

Responsible AI: The key to clinical decision-making

Responsible AI refers to the ethical and accountable development of AI systems before deployment. It also involves considering the social, ethical, and legal implications of AI technologies, and ensures that AI systems are designed to be used in ways that align with human values while protecting patient data and privacy. Predicting patient outcomes is one of the most promising applications of responsible AI in healthcare.

Predictive AI models can detect areas of concern by analyzing laboratory test results, potentially uncovering risks before symptoms become apparent. The healthcare industry is increasingly utilizing responsible AI for predictive analytics, leveraging patient datasets to forecast the probability of specific diseases or disorders. This may include early diagnosis and treatment for cancer patients by assessing a patient’s risk of developing cancer or chronic illnesses like heart disease, thereby enabling proactive interventions such as lifestyle modifications or medication adjustments. AI also demonstrates remarkable potential for identifying and diagnosing traditionally challenging conditions, including rare hereditary and neurodegenerative diseases. This predictive capability has the potential to save lives via faster diagnoses and effective treatments, thus reducing the burden on health systems and decreasing costly hospital bills.

As AI evolves to play a more critical role in healthcare, it is imperative to integrate responsible AI principles into every aspect of its implementation. While AI can significantly enhance patient care, its use must be guided by ethical principles, ensuring that human dignity and autonomy are respected. Decisions involving AI should not replace human judgment but rather complement it.

By applying responsible AI to ever-expanding reservoirs of patient data, the healthcare industry can enhance clinical decision-making and gain deeper insights into diseases, treatment options, and care delivery. A responsible, predictive AI model that assesses an individual’s combined genetic, behavioral, and social data holds great potential for enhancing a physician’s ability to tailor care paths and medications to each unique patient. However, predicting patient outcomes isn’t the only aspect of AI in which healthcare professionals are investing.

AI tools, such as generative GenAI, are becoming increasingly deployed to automate labor-intensive and error-prone operational tasks, granting clinicians instant access to years of clinical data and modernizing the healthcare system’s infrastructure. Projections indicate that implementing AI tools within the U.S. healthcare system can yield annual savings of anywhere between $200 billion and $360 billion.

GenAI is simplifying the prior authorization process by replacing traditional systems–often slow and cumbersome–with one that prioritizes evidence-based treatments from the start. This reduces the need for lengthy prior authorization assessments and guarantees swift access to treatment. GenAI also streamlines the time-consuming administrative tasks related to prior authorizations that consume physicians’ valuable time and resources, freeing up more time for patient care.

Pairing AI with patient data will reshape the healthcare landscape, offering unprecedented insights into patient outcomes and the potential for more personalized care. By weaving responsible AI into healthcare, we can create a future where better health outcomes are achievable and accessible to all, building healthier and more equitable communities.

Published On: October 30th, 2023Categories: AI/ML National Media, News

Share:

About the Author: Brian Covino, M.D., FAAOS

Dr. Brian Covino oversees more than 50 physicians as Cohere Health’s Chief Medical Officer. After practicing orthopedic surgery for more than 25 years, Dr. Covino joined Cohere in 2020 after having served as a consultant since 2018. During his years as a practicing surgeon, Dr. Covino was a partner at Knoxville Orthopaedic Clinic/OrthoTennessee specializing in joint replacement surgery. He holds a bachelor’s from Harvard University as well as an M.D. from Georgetown University School of Medicine. Dr. Covino received his surgical training at the University of Virginia Graduate School of Medical Education and completed a fellowship at The Cleveland Clinic Foundation.